Published in Front Mol Neurosci on May 08, 2017
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat (2004) 13.18
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care (2000) 8.63
Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect (2011) 6.48
Alcoholic liver disease. Hepatology (2010) 5.04
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care (2007) 4.42
Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med (1998) 4.29
Nonalcoholic fatty liver disease. Gastroenterology (2002) 4.15
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology (1990) 3.63
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 3.57
Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry (2003) 2.77
The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine (1998) 2.70
Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia (2010) 2.50
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology (2003) 2.28
Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry (2011) 2.23
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology (2014) 2.22
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther (2014) 2.04
Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology (1994) 2.02
Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs (2005) 1.93
Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry (2009) 1.93
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med (1997) 1.91
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology (2003) 1.86
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry (2008) 1.80
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology (2007) 1.79
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation (2013) 1.78
A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care (2007) 1.74
Association Between Psychological Distress and Liver Disease Mortality: A Meta-analysis of Individual Study Participants. Gastroenterology (2015) 1.73
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry (2002) 1.73
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry (2008) 1.73
A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend (2001) 1.73
IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog (2013) 1.67
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry (2008) 1.66
Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis (2005) 1.62
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60
Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry (2008) 1.59
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58
Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry (2004) 1.52
Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology (2002) 1.47
Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One (2013) 1.47
Life events, depressive symptoms, and immune function. Am J Psychiatry (1987) 1.42
Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant (2009) 1.39
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J Hepatol (2012) 1.32
Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res (2000) 1.32
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord (2002) 1.30
Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C. Gastroenterology (2007) 1.29
Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.28
Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis (2002) 1.27
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol (2004) 1.24
A systematic review of variables associated with the relationship between obesity and depression. Obes Rev (2013) 1.24
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int (2013) 1.22
Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism (2000) 1.21
Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry (2005) 1.18
Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther (2006) 1.18
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology (2010) 1.17
A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol (2000) 1.15
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci (2003) 1.13
NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl) (2014) 1.13
Understanding the health impact of alcohol dependence. Am J Health Syst Pharm (2007) 1.13
Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol (2015) 1.13
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut (2006) 1.11
Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab (2008) 1.11
NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun (2014) 1.09
Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat (2011) 1.09
Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom Med (2006) 1.09
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health (2007) 1.08
Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics (2001) 1.06
Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res (2007) 1.04
Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci (2001) 1.04
Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol (2005) 1.04
Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med (2005) 1.03
Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant (2011) 1.02
Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry (2003) 1.01
Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention. Can J Infect Dis Med Microbiol (2009) 1.01
Psychiatric disorders and functioning in hepatitis B virus carriers. Psychosomatics (2005) 1.01
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C. Mol Psychiatry (2011) 1.01
Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry (2003) 0.99
Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience (2015) 0.99
Neurobehavioral effects of interferon therapy. Curr Psychiatry Rep (2005) 0.98
Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics (2011) 0.98
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol (2010) 0.97
Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Curr Drug Metab (2000) 0.96
Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C. Psychosomatics (2002) 0.95
Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl (2007) 0.94
Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl (2013) 0.94
Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res (2011) 0.94
Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms. J Psychopharmacol (2004) 0.93
Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci (1997) 0.93
Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh) (2009) 0.90
Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases. Mol Cells (2014) 0.90
Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology (2012) 0.90
Alcohol consumption and major depression in the general population: the critical importance of dependence. Depress Anxiety (2012) 0.89
Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci Ther (2013) 0.89